Real-time energy/mass transfer mapping for online 4D dose reconstruction.
Ontology highlight
ABSTRACT:
SUBMITTER: Ziegenhein P
PROVIDER: S-EPMC5827544 | biostudies-literature | 2018 Feb
REPOSITORIES: biostudies-literature
Publications
Real-time energy/mass transfer mapping for online 4D dose reconstruction.
Ziegenhein Peter P Kamerling Cornelis Ph CP Fast Martin F MF Oelfke Uwe U
Scientific reports 20180226 1
In this work we describe an ultra-fast, low-latency implementation of the energy/mass transfer (EMT) mapping method to accumulate dose on deforming geometries such as lung using the central processing unit (CPU). It enables the computation of the actually delivered dose for intensity-modulated radiation therapy on 4D image data in real-time at 25 Hz. In order to accumulate the delivered dose onto a reference phase a pre-calculated deformable vector field is used. The aim of this study is to pres ...[more]
Similar Datasets
Project description:This study provides a proof of concept for real-time 4D dose reconstruction for lung stereotactic body radiation therapy (SBRT) with multileaf collimator (MLC) tracking and assesses the impact of tumor tracking on the size of target margins.The authors have implemented real-time 4D dose reconstruction by connecting their tracking and delivery software to an Agility MLC at an Elekta Synergy linac and to their in-house treatment planning software (TPS). Actual MLC apertures and (simulated) target positions are reported to the TPS every 40 ms. The dose is calculated in real-time from 4DCT data directly after each reported aperture by utilization of precalculated dose-influence data based on a Monte Carlo algorithm. The dose is accumulated onto the peak-exhale (reference) phase using energy-mass transfer mapping. To investigate the impact of a potentially reducible safety margin, the authors have created and delivered treatment plans designed for a conventional internal target volume (ITV) + 5 mm, a midventilation approach, and three tracking scenarios for four lung SBRT patients. For the tracking plans, a moving target volume (MTV) was established by delineating the gross target volume (GTV) on every 4DCT phase. These were rigidly aligned to the reference phase, resulting in a unified maximum GTV to which a 1, 3, or 5 mm isotropic margin was added. All scenarios were planned for 9-beam step-and-shoot IMRT to meet the criteria of RTOG 1021 (3 × 18 Gy). The GTV 3D center-of-volume shift varied from 6 to 14 mm.Real-time dose reconstruction at 25 Hz could be realized on a single workstation due to the highly efficient implementation of dose calculation and dose accumulation. Decreased PTV margins resulted in inadequate target coverage during untracked deliveries for patients with substantial tumor motion. MLC tracking could ensure the GTV target dose for these patients. Organ-at-risk (OAR) doses were consistently reduced by decreased PTV margins. The tracked MTV + 1 mm deliveries resulted in the following OAR dose reductions: lung V20 up to 3.5%, spinal cord D2 up to 0.9 Gy/Fx, and proximal airways D2 up to 1.4 Gy/Fx.The authors could show that for patient data at clinical resolution and realistic motion conditions, the delivered dose could be reconstructed in 4D for the whole lung volume in real-time. The dose distributions show that reduced margins yield lower doses to healthy tissue, whilst target dose can be maintained using dynamic MLC tracking.
| S-EPMC5965366 | biostudies-other
Project description:Due to the combination of high-frequency use and relatively high diagnostic radiation dose (>9 mSv for one scan), there is a need to lower the radiation dose used in myocardial perfusion imaging (MPI) studies in cardiac gated single photon emission computed tomography (GSPECT) in order to reduce its population based cancer risk. The aim of this study is to assess quantitatively the potential utility of advanced 4D reconstruction for GSPECT for significantly lowered imaging dose.For quantitative evaluation, Monte Carlo simulation with the 4D NURBS-based cardiac-torso (NCAT) phantom is used for GSPECT imaging at half and quarter count levels in the projections emulating lower injected activity (dose) levels. Both 4D and 3D reconstruction methods are applied at these lowered dose levels, and compared with standard clinical spatiotemporal reconstruction (ST121) at full dose using a number of metrics on the reconstructed images: (1) overall reconstruction accuracy of the myocardium, (2) regional bias-variance analysis of the left ventricle (LV) wall, (3) uniformity of the LV wall, (4) accuracy of the time activity curve (TAC) of the LV wall, and (5) detectability of perfusion defects using channelized Hotelling observer. As a preliminary demonstration, two sets of patient data acquired in list-mode are used to illustrate the conservation of both image quality and LV ejection fraction (LVEF) by 4D reconstruction where only a portion of the acquired counts at each projection angle are used to mimic low-dose acquisitions.Compared to ST121 at standard dose, even at quarter dose 4D achieved better performance on overall reconstruction accuracy of the myocardium (28.7% improvement on relative root mean square error: standard vs 4D quarter p-value < 10(-30)), regional bias-variance analysis, and similar performance on accuracy of the TAC of the LV wall and detectability of perfusion defects. A slight degradation in uniformity of the LV wall was observed in 4D at quarter dose due to use of scatter correction which increases reconstruction variance. The reconstructed images from simulated and patient data show that 4D at quarter dose is visually comparable to ST121 at standard dose, if not better. Compared to ST121 and 3D, 4D images exhibit less noise artifacts and better definition of the LV wall. The 4D images are also observed to be more consistent between half dose and quarter dose. 4D also yields more consistent LVEF results at different count levels on the patient data.With various quantitative metrics 4D reconstruction is demonstrated to achieve better or comparable performance at quarter dose (∼2.25 mSv, 75% dose reduction) compared to conventional clinical reconstruction at standard dose (∼9 mSv). Preliminary results from two patient datasets also show that 4D at an equivalent quarter dose can achieve better performance than clinical and 3D methods at higher dose levels. Such a significant dose reduction (75%) has not been demonstrated quantitatively in previous studies in GSPECT. These promising results warrant further investigations on the lower bound of dose reduction with different reconstruction strategies and more comprehensive clinical studies with greater patient variability.
| S-EPMC3555964 | biostudies-other
Project description:We have developed a novel method for real-time monitoring of RNA synthesis in in vitro transcription reactions using fluorescence resonance energy transfer (FRET). Two 15mer DNAs, either of which was labeled with Bodipy493/503 as a donor or Cy5 as an acceptor, were prepared. When the two fluorescent DNAs hybridized to adjacent locations on Xenopus: elongation factor 1-alpha (xelf1-alpha) RNA, the distance between the two fluorophores became very close, causing FRET to occur and resulting in changes in fluorescence spectra. A high accessibility 30mer site of xelf1-alpha RNA was found and excess amounts of a pair of donor and acceptor DNA probes that were complementary to the site were added to the in vitro transcription reaction solution. Changes in fluorescence spectra were observed in response to progression of xelf1-alpha RNA synthesis that showed that the fluorescent probes hybridized to the synthesized RNA. Furthermore, when probes hybridizing to the synthesized xelf1-alpha RNA with less efficiency were used to monitor the reaction, spectral changes in response to RNA synthesis were also observed. This result suggests that the probes hybridized to synthesizing RNA molecules before they folded to form secondary structure and that there is no need to select sites on the RNA for the probes, which is required for probes hybridizing to folded RNA molecules.
| S-EPMC102744 | biostudies-literature
Project description:A real-time PCR targeting the gyrase A subunit gene outside the quinolone resistance-determining region has been developed to detect Arcobacter species. The species identification was done by probe hybridization and melting curve analysis, using fluorescence resonance energy transfer technology. Discrimination between Arcobacter species was straightforward, as the corresponding melting points showed significant differences with the characteristic melting temperatures of 63.5 degrees C, 58.4 degrees C, 60.6 degrees C, and 51.8 degrees C for the Arcobacter butzleri, Arcobacter cryaerophilus, Arcobacter cibarius, and Arcobacter nitrofigilis type strains, respectively. The specificity of this assay was confirmed with pure cultures of 106 Arcobacter isolates from human clinical and veterinary specimens identified by phenotypic methods and 16S rRNA gene sequencing. The assay was then used to screen 345 clinical stool samples obtained from patients with diarrhea. The assay detected A. butzleri in four of these clinical samples (1.2%). These results were confirmed by a conventional PCR method targeting the 16S rRNA gene with subsequent sequencing of the PCR product. In conclusion, this real-time assay detects and differentiates Arcobacter species in pure culture as well as in the competing microbiota of the stool matrix. The assay is economical since only one biprobe is used and multiple Arcobacter species are identified in a single test.
| S-EPMC2045264 | biostudies-literature
Project description:Calculation of four-dimensional (4D) dose distributions requires the remapping of dose calculated on each available binned phase of the 4D CT onto a reference phase for summation. Deformable image registration (DIR) is usually used for this task, but unfortunately almost always considers only endpoints rather than the whole motion path. A new algorithm, 4D tissue deformation reconstruction (4D TDR), that uses either CT projection data or all available 4D CT images to reconstruct 4D motion data, was developed. The purpose of this work is to verify the accuracy of the fit of this new algorithm using a realistic tissue phantom. A previously described fresh tissue phantom with implanted electromagnetic tracking (EMT) fiducials was used for this experiment. The phantom was animated using a sinusoidal and a real patient-breathing signal. Four-dimensional computer tomography (4D CT) and EMT tracking were performed. Deformation reconstruction was conducted using the 4D TDR and a modified 4D TDR which takes real tissue hysteresis (4D TDR(Hysteresis)) into account. Deformation estimation results were compared to the EMT and 4D CT coordinate measurements. To eliminate the possibility of the high contrast markers driving the 4D TDR, a comparison was made using the original 4D CT data and data in which the fiducials were electronically masked. For the sinusoidal animation, the average deviation of the 4D TDR compared to the manually determined coordinates from 4D CT data was 1.9 mm, albeit with as large as 4.5 mm deviation. The 4D TDR calculation traces matched 95% of the EMT trace within 2.8 mm. The motion hysteresis generated by real tissue is not properly projected other than at endpoints of motion. Sinusoidal animation resulted in 95% of EMT measured locations to be within less than 1.2 mm of the measured 4D CT motion path, enabling accurate motion characterization of the tissue hysteresis. The 4D TDR(Hysteresis) calculation traces accounted well for the hysteresis and matched 95% of the EMT trace within 1.6 mm. An irregular (in amplitude and frequency) recorded patient trace applied to the same tissue resulted in 95% of the EMT trace points within less than 4.5 mm when compared to both the 4D CT and 4D TDR(Hysteresis) motion paths. The average deviation of 4D TDR(Hysteresis) compared to 4D CT datasets was 0.9 mm under regular sinusoidal and 1.0 mm under irregular patient trace animation. The EMT trace data fit to the 4D TDR(Hysteresis) was within 1.6 mm for sinusoidal and 4.5 mm for patient trace animation. While various algorithms have been validated for end-to-end accuracy, one can only be fully confident in the performance of a predictive algorithm if one looks at data along the full motion path. The 4D TDR, calculating the whole motion path rather than only phase- or endpoints, allows us to fully characterize the accuracy of a predictive algorithm, minimizing assumptions. This algorithm went one step further by allowing for the inclusion of tissue hysteresis effects, a real-world effect that is neglected when endpoint-only validation is performed. Our results show that the 4D TDR(Hysteresis) correctly models the deformation at the endpoints and any intermediate points along the motion path.
| S-EPMC5713919 | biostudies-literature
Project description:Mainstream tobacco smoke is a complex and dynamic aerosol, consisting of particulate and vapour phases. Most approaches to determine mainstream smoke toxicant yields are based on offline techniques that limit the opportunity to observe in real time the processes leading to smoke formation. The recent development of online real-time analytical methods offers many advantages over traditional techniques. Here we report the LM2X-TOFMS (Borgwaldt GmbH, Germany), a commercial instrument that couples a linear smoking engine with a time-of-flight mass spectrometer for real-time per-puff measurement of the vapour phase of mainstream cigarette smoke. Total cigarette and puff-by-puff (μg/puff) yields were evaluated, in line with International Council of Harmonisation recommendations, for seven smoke toxicants: acetaldehyde, acetone, 1,3-butadiene, 2-butanone, benzene, isoprene and toluene. Measurements were unaffected by small system changes including replacing the sampling capillary or time of day (all P > 0.05), indicating that the LM2X-TOFMS is rugged. Control charts showed that the system has good stability and control. Analysis of certified gas mixtures of six concentrations of each analyte showed a highly linear response for all seven analytes (R2 = 0.9922-0.9999). In terms of repeatability, the lowest variation was observed for isoprene with a coefficient of variation (CV) of < 6% for each concentration. Acetaldehyde showed the highest CV, increasing from 8.0 to 26.6% with decreasing gas concentration. Accuracy was analysed in terms of relative error, which was ± 16% for six of the analytes; however, the relative error for acetaldehyde was (- 36.2%), probably due to its low ionisation efficiency under the instrument's vacuum ultraviolet lamp. Three cigarette products (reference and commercial) with different ISO tar levels were analysed by the LM2X-TOFMS puff by puff under ISO regulatory smoking conditions. The relative standard deviation based on average yield per cigarette for each analyte in each product (summed puffs per product, n = 30) ranged from ≤ 9.3 to ≤ 16.2%. Measurements were consistent with published data per cigarette. In conclusion, the LM2X-TOFMS is suitable for determining the vapour-phase yields of seven analytes on a real-time, puff-by-puff basis, and can be utilised for both fast screening (qualitative) and quantitative measurements of mainstream cigarette smoke.
| S-EPMC6925416 | biostudies-literature
Project description:Despite the initial effectiveness of oncogene-directed cancer therapeutics, acquired drug resistance remains the ultimate "Achilles' heel" for long-term durable remission in cancer patients. Acquisition of drug resistance is not more evident elsewhere than in the use of tyrosine kinase inhibitors, imatinib and dasatinib, for patients with chronic myelogenous leukemia. Hence, even though imatinib initially produces remission in the chronic phase, ultimately these therapeutics fail via the emergence of drug resistance, in which chronic myelogenous leukemia could inevitably progress to a terminal blast phase culminating in fatal outcome. Technically, it is challenging to predict the onset of drug resistance in a small number of oncogene-transformed cells, making the decision of when and how to employ second-generation tyrosine kinase inhibitors, or employ novel compounds that would be of benefit in treating drug-resistant Bcr-Abl mutants mainly retrospective. Here, we characterize a rapid and sensitive real-time fluorescent resonance energy transfer-based assay that is able to detect the in vivo activity of Bcr-Abl and its inhibition by small molecule compounds. Due to its real-time and in vivo nature, such an approach has the potential to monitor a drug-resistant phenotype, as well as to identify pharmaceutical agents that inhibit drug-resistant Bcr-Abl oncoproteins in vivo.
| S-EPMC3318989 | biostudies-literature
Project description:Described in the article is a new approach for the sequence-specific detection of nucleic acids in real-time polymerase chain reaction (PCR) using fluorescently labeled oligonucleotide probes. The method is based on the production of PCR amplicons, which fold into dumbbell-like secondary structures carrying a specially designed 'probe-luring' sequence at their 5' ends. Hybridization of this sequence to a complementary 'anchoring' tail introduced at the 3' end of a fluorescent probe enables the probe to bind to its target during PCR, and the subsequent probe cleavage results in the florescence signal. As it has been shown in the study, this amplicon-endorsed and guided formation of the probe-target duplex allows the use of extremely short oligonucleotide probes, up to tetranucleotides in length. In particular, the short length of the fluorescent probes makes possible the development of a 'universal' probe inventory that is relatively small in size but represents all possible sequence variations. The unparalleled cost-effectiveness of the inventory approach is discussed. Despite the short length of the probes, this new method, named Angler real-time PCR, remains highly sequence specific, and the results of the study indicate that it can be effectively used for quantitative PCR and the detection of polymorphic variations.
| S-EPMC3814350 | biostudies-literature
Project description:Using as showcase the DNA dinucleotide 5'-dTpdG-3', in which the thymine (T) is located at the 5' end with respect to the guanine (G), we study the photoinduced electronic relaxation of coupled chromophores in solution with an unprecedented refinement. On the one hand, transient absorption spectra are recorded from 20 fs to 45 ps over the 330-650 nm range with a temporal resolution of 30 fs; on the other hand, quantum chemistry calculations determine the ground state geometry of the 4 possible conformers with stacked nucleobases, the associated Franck-Condon states, and map the relaxation pathways leading to excited state minima. Important spectral changes occurring before 100 fs are correlated with concomitant G+ → T- charge transfer and T → G energy transfer processes. The lifetime of the excited charge transfer state is only 5 ps and the absorption spectrum of a long-lived nπ*T state is detected. Our experimental results match the transient spectral properties computed for the anti-syn conformer of 5'-dTpdG-3', which is characterized by the lowest ground state energy and differs from that encountered in B-form duplexes.
| S-EPMC11290326 | biostudies-literature
Project description:The XCAT phantom is a realistic 4D digital torso phantom that is widely used in imaging and therapy research. However, lung mass is not conserved between respiratory phases of the phantom, making detailed dosimetric simulations and dose accumulation unphysical. A framework is developed to correct this issue by enforcing local mass conservation in the XCAT lung. Dose calculations are performed to assess the implications of neglecting mass conservation, and to demonstrate an application of the phantom to calculate the accumulated delivered dose in an irregularly breathing patient.A displacement vector field (DVF) between each respiratory state and a reference image is generated from the XCAT motion model and its divergence is calculated and used to correct the lung density. A series of phantoms with regular and irregular breathing (based on patient data) are generated and modified to conserve mass. Monte Carlo methods are used to simulate conventional and SBRT treatment delivery. The calculated dose is deformed and accumulated using the DVF. Results from the mass-conserving and original XCAT are compared. A 4DCT is simulated for the irregularly breathing patient, and a 4DCT-based dose estimate is compared with the accumulated delivered dose.The presented framework successfully conserves mass in the XCAT lung. The spatial distribution of the lung dose was qualitatively changed by the use of a mass conservation in the XCAT; however, the corresponding DVH did not change significantly. The comparison of the delivered dose with the 4DCT-based prediction shows similar lung metric results, however dose differences of 10% can be seen in some spatial regions.The XCAT phantom has been successfully modified so that it conserves lung mass during respiration, enabling it to be used as a tool to perform dose accumulation studies in the lung without relying on deformable image registration. Neglecting mass conservation can result in erroneous spatial distributions of the dose in the lung. Using this tool to simulate patient treatments reveals differences between the planned dose and the calculated delivered dose for the full treatment. The software is freely available from the authors.
| S-EPMC3710255 | biostudies-other